Lung cancer screening with low-dose computed tomography can reduce death from lung
cancer by 20–24% in high-risk smokers. National lung cancer screening programmes have …

Simple Summary Lung cancer is a widespread malignant tumour with a high mortality and
morbidity rate and is frequently diagnosed in the middle and late stages when few therapies …

PURPOSE To investigate whether a panel of circulating protein biomarkers would improve
risk assessment for lung cancer screening in combination with a risk model on the basis of …

PURPOSE This meta-analysis aims to combine and analyze randomized clinical trials
comparing computed tomography lung screening (CTLS) versus either no screening (NS) or …

Computer tomography (CT) has played an essential role in the field of medical diagnosis,
but the blurry edges and unclear textures in traditional CT images usually interfere the …

Smoking is the main risk factor for lung cancer (LC), which is the leading cause of cancer-
related death worldwide. Independent randomized controlled trials, governmental and inter …

Asbestos exposure is the most important cause of occupational lung cancer mortality. Two
large randomized clinical trials in the US and Europe conclusively demonstrate that annual …

The ITALUNG trial started in 2004 and compared lung cancer (LC) and other-causes
mortality in 55–69 years-aged smokers and ex-smokers who were randomized to four …

As one of the most reliable and significant indicators, Chronic Obstructive Pulmonary
Disease (COPD) becomes a robust predictor of lung cancer early detection, the world's …

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality
worldwide. Despite advances in treatment, the prognosis remains poor, highlighting the …